Investment Firms in Shenzhen, China
Known as a global hardware manufacturing and innovation center, its venture capital ecosystem is deeply integrated with a dense supply chain and rapid prototyping capabilities. The city is a prominent hub for investments in fintech, e-commerce, and mobility, often supporting companies from early to late growth stages. This environment stems from its historical role as China's first Special Economic Zone, fostering a pragmatic and execution-oriented startup culture.
Shenzhen, China's investment landscape is shaped by Healthcare, with 80% of its 5 investment firms focused on this sector. The most active by portfolio size are Tencent Investment, Shenzhen Capital Group, and Welight Capital.
Healthcare dominates the investment landscape in Shenzhen, with 80% of investment firms focused on this sector.
Shenzhen is a particularly strong hub for early-stage investing, with over 100% of investment firms active at the Seed or Pre-Seed stage.
Last updated: 9 September 2026
Investment Firms
5
Total Investments
181
Top Sector
Healthcare
Top Stage
Series A
Top Investment Sectors in Shenzhen
The most popular sector focus among Shenzhen investment firms is Healthcare, with 4 investment firms (80%) investing in the space. This is followed by Fintech (3), AI (3), Consumer (2), E-Commerce & Marketplace (2).
Investment Stages in Shenzhen
Shenzhen investment firms are most active at the Series A stage (5 investment firms). This is followed by Seed (5), Series C (4), Series B (4), Growth (3).
Tencent Investment
Shenzhen, China
130 investments
Growth, Series C
Gaming, Fintech, AI …
Shenzhen Capital Group
Shenzhen, China
28 investments
Series B, Series A
AI, Biotech & Life Sciences, Hardware & Semiconductors …
Welight Capital
Shenzhen, China
11 investments
Seed, Series A
Enterprise Software, E-Commerce & Marketplace, Fintech …
Green Pine Capital Partners
Shenzhen, China
8 investments
Series A, Series B
AI, Biotech & Life Sciences, Healthcare …
Ping An
Shenzhen, China
4 investments
Growth, Series A
Insurance, Healthcare, Fintech